| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| foundationone cdx msi | 0.09 | 0.5 | 6217 | 86 | 21 |
| foundationone | 1.48 | 0.9 | 4358 | 5 | 13 |
| cdx | 1.45 | 1 | 7011 | 94 | 3 |
| msi | 0.92 | 0.9 | 5916 | 64 | 3 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| foundationone cdx msi | 1.76 | 0.4 | 8088 | 55 |
Overview What is FoundationOne CDx? FoundationOne CDx is the first FDA-approved tissue-based broad companion diagnostic (CDx) that is clinically and analytically validated for all solid tumors.
What is MSI status for FoundationOne Liquid CDX?† MSI status will be reported for FoundationOne Liquid CDx samples determined to have high microsatellite instability as a laboratory professional service which is not reviewed or approved by the FDA.
Does FoundationOne CDx report TMB scores?Currently FoundationOne CDx, FoundationOne Liquid CDx,* and FoundationOne Heme report TMB scores. As TMB is a quantitative genomic signature, current clinical trials are assessing therapeutic response at various cut-off levels in different tumor types.
Are FoundationOne®CDx and FoundationOne® Liquid CDX tests approved for NGS testing?Our FoundationOne®CDx and FoundationOne®Liquid CDx tests have 60% of all CDx approvals for NGS testing in the United States and Japan – the most of any diagnostic company 1
